John Wiley and Sons: Researchers Assess Cognitive Impairment in Patients With Breast Cancer
February 04, 2021
February 04, 2021
HOBOKEN, New Jersey, Feb. 4 (TNSJou) -- John Wiley and Sons issued the following news release:
A recent analysis of published studies estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy. The analysis, which is published in Psycho-Oncology, also found that many patients' cognitive function declines after receiving chemotherapy, endocrine therapy, and/or hormone therapy for breast cancer.
"Our results suggest . . .
A recent analysis of published studies estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy. The analysis, which is published in Psycho-Oncology, also found that many patients' cognitive function declines after receiving chemotherapy, endocrine therapy, and/or hormone therapy for breast cancer.
"Our results suggest . . .